Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravitreal Bevacizumab Injection”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Large-scale testing (Phase 3)Study completedNCT02308644
What this trial is testing

Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study

Who this might be right for
Diabetic Macular Edema
University of Sao Paulo 41
Post-approval studies (Phase 4)Study completedNCT00737971
What this trial is testing

Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Rubens Belfort Jr. 142
Not applicableStudy completedNCT04827836
What this trial is testing

Pain Control and Subconjunctival Hemorrhage Size After Intravitreal Injection

Who this might be right for
Intravitreal InjectionPainSubconjunctival Hemorrhage
Wolfson Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01982435
What this trial is testing

Safety and Efficacy of Ranibizumab for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Justis Ehlers 27
Large-scale testing (Phase 3)UnknownNCT00370422
What this trial is testing

Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial

Who this might be right for
Diabetic Macular Edema
Shahid Beheshti University of Medical Sciences
Testing effectiveness (Phase 2)UnknownNCT04800679
What this trial is testing

Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR

Who this might be right for
Proliferative Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences 105
Testing effectiveness (Phase 2)Study completedNCT02663141
What this trial is testing

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Tehran University of Medical Sciences 57
Post-approval studies (Phase 4)Study completedNCT00557232
What this trial is testing

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Who this might be right for
GlaucomaRubeosis Iridis
Instituto de Olhos de Goiania 25
Not applicableLooking for participantsNCT03648814
What this trial is testing

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Who this might be right for
Glaucoma, NeovascularVascular Endothelial Growth Factor Overexpression
Prince of Songkla University 40
Testing effectiveness (Phase 2)UnknownNCT01091896
What this trial is testing

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage

Who this might be right for
Vitreous Hemorrhage Secondary to PDR
University of Sao Paulo 1
Not applicableStudy completedNCT00423059
What this trial is testing

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Yonsei University 20
Early research (Phase 1)Study completedNCT00406250
What this trial is testing

Intravitreal Bevacizumab in Agioid Streaks

Who this might be right for
Angioid StreaksChoroidal Neovascularization
University of Campania Luigi Vanvitelli 5
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Testing effectiveness (Phase 2)UnknownNCT00684853
What this trial is testing

Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

Who this might be right for
Macular Degeneration
Federal University of São Paulo 50
Not applicableStudy completedNCT02140450
What this trial is testing

Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

Who this might be right for
Intraocular Pressure Change in Intravitreal Injection
Mashhad University of Medical Sciences 70
Testing effectiveness (Phase 2)Study completedNCT01471691
What this trial is testing

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Who this might be right for
Branch Retinal Vein OcclusionCentral Retinal Vein OcclusionMacular Edema
Hanscom, Thomas, M.D. 14
Not applicableUnknownNCT02090322
What this trial is testing

Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1

Who this might be right for
Retinopathy of Prematurity
Universidad Autonoma de San Luis Potosí 60
Not applicableStudy completedNCT01614509
What this trial is testing

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Yeungnam University College of Medicine 45
Not applicableStudy completedNCT01032109
What this trial is testing

Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Kumamoto University 45
Post-approval studies (Phase 4)Study completedNCT03148132
What this trial is testing

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Who this might be right for
Retinopathy of Prematurity Both EyesRetinal DiseasePremature Birth+1 more
Universidad Autonoma de San Luis Potosí 16
Load More Results